BioSpace News Archive

Drug Development

AbbVie Presents Positive Results from Phase 3 SELECT-AXIS 2 Trials of Upadacitinib (RINVOQ®) in Patients with Axial Spondyloarthritis at EULAR 2022

AbbVie (NYSE: ABBV) today announced the presentation of full results from two studies from the Phase 3 SELECT-AXIS 2 program evaluating upadacitinib (RINVOQ®).

June 1, 2022
·
17 min read
3D Printing Healthcare Market Valuation Worth USD 4,070.8 Million in 2027 | Emergen Research

Increasing prevalence of cardiovascular diseases and orthopedic disorders worldwide, rising demand for contact lenses, dental implants, hearing aids, and prosthetics, increasing geriatric population, and rapid advancements in 3D printing are some key factors expected to drive global market growth.

June 1, 2022
·
6 min read
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Valuation Worth USD 29.32 Billion in 2027 | Emergen Research

Rising prevalence of cardiovascular diseases across the globe, rapid advancements in cardiac monitoring and cardiac rhythm management technology, and increasing R&D investments are some key factors expected to drive global market growth.

June 1, 2022
·
6 min read
Clinical Perinatal Software Market Valuation Worth 393.3 Million in 2027 | Emergen Research

Rising birth rate across the globe, rapid technological upgrades in the perinatal software, and increasing government initiatives to promote clinical perinatal software and tools are some key factors expected to drive global market revenue growth.

June 1, 2022
·
5 min read
Digital Biomarkers Market Valuation Worth USD 10.38 billion in 2027 | Emergen Research

Rising incidence of various chronic disorders and infectious diseases across the globe, increasing adoption of hand held and wearable digital devices, and rapid development in IT and telecommunication sector are some key factors expected to drive global market growth.

June 1, 2022
·
5 min read
Medical Devices Testing Services Market Valuation Worth USD 14.25 Billion in 2027 | Emergen Research

Increasing incidence of various chronic diseases across the globe, growing demand for in-vitro tests, and rising focus on developing advanced medical devices testing services are some key factors expected to drive global market growth.

June 1, 2022
·
5 min read
Nerve Repair and Regeneration Market Valuation Worth USD 11.62 Billion in 2027 | Emergen Research

Increasing prevalence neurodegenerative disorders, rising geriatric population, and high focus on developing advanced nerve repair and regeneration devices are some factors expected to drive global market growth.

June 1, 2022
·
5 min read
Oligonucleotide Synthesis Market Valuation Worth USD 9.91 Billion By 2027 | Emergen Research

Increasing prevalence of various genetic disorders, chronic diseases and viral infections, rising research based activities in pharmaceutical and biotechnology companies, and increasing applications of synthesized oligonucleotides are some key factors expected to drive global market growth.

June 1, 2022
·
5 min read
Spinal Fusion Devices Market Valuation Worth USD 8.90 Billion in 2027 | Emergen Research

Increasing prevalence of degenerative disc disease, rising geriatric population, and increasing cases of road accidents and fatal falls worldwide are some key factors expected to drive global market growth.

June 1, 2022
·
6 min read
BioMidwest

Arjo Announces New Single-Use Intraoperative Doppler System

With over 30 years’ experience in vascular assessment, Huntleigh, a member of the Arjo family, has strived to provide patients, and the professionals who care for them, innovative solutions that improve outcomes and enhance patient well being.

June 1, 2022
·
2 min read